Published in PLoS One on September 09, 2013
Liver resection for young patients with large hepatocellular carcinoma: a single center experience from China. World J Surg Oncol (2014) 0.85
Non-alcoholic fatty liver disease, diet and gut microbiota. EXCLI J (2014) 0.81
Host and tumor derived MMP13 regulate extravasation and establishment of colorectal metastases in the liver. Mol Cancer (2015) 0.79
Loss of miR-532-5p in vitro promotes cell proliferation and metastasis by influencing CXCL2 expression in HCC. Am J Transl Res (2015) 0.79
Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells. PLoS One (2016) 0.78
The double trouble of metabolic diseases: the diabetes-cancer link. Mol Biol Cell (2015) 0.76
Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotype. Hepatology (2016) 0.75
Characterization of long non-coding RNA transcriptome in high-energy diet induced nonalcoholic steatohepatitis minipigs. Sci Rep (2016) 0.75
Kupffer Cell Metabolism and Function. J Enzymol Metab (2015) 0.75
Chemokines and their receptors play important roles in the development of hepatocellular carcinoma. World J Hepatol (2015) 0.75
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer (2004) 16.69
Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology (2006) 9.34
Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell (2010) 8.04
Human fatty liver disease: old questions and new insights. Science (2011) 8.03
Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology (2010) 5.44
The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology (2010) 4.83
NF-κB and STAT3 - key players in liver inflammation and cancer. Cell Res (2010) 4.10
Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology (2004) 3.93
Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med (2000) 3.47
Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology (2012) 2.85
Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology (2001) 2.69
The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. Am J Respir Cell Mol Biol (2006) 2.68
Pathophysiology of nonalcoholic steatohepatitis. J Clin Gastroenterol (2006) 2.59
Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am J Physiol Gastrointest Liver Physiol (2002) 2.46
Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology (2003) 2.45
Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice. Hepatology (2013) 2.42
Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab (2006) 2.31
Inflammatory pathways in liver homeostasis and liver injury. Clin Rev Allergy Immunol (2009) 2.27
Role of CXCL1 in tumorigenesis of melanoma. J Leukoc Biol (2002) 2.13
Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut (2011) 2.06
Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2. Am J Physiol Gastrointest Liver Physiol (2012) 1.87
Role of Kupffer cells in the pathogenesis of liver disease. World J Gastroenterol (2006) 1.84
Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production. J Biol Chem (2012) 1.75
Cytokine regulation of liver injury and repair. Immunol Rev (2000) 1.58
Non-alcoholic steatohepatitis: from cell biology to clinical practice. J Hepatol (2005) 1.54
CCL9 is secreted by the follicle-associated epithelium and recruits dome region Peyer's patch CD11b+ dendritic cells. J Immunol (2003) 1.54
Exacerbation of established pulmonary fibrosis in a murine model by gammaherpesvirus. Am J Respir Crit Care Med (2008) 1.53
Interleukin-10 is a protective factor against diet-induced insulin resistance in liver. J Hepatol (2008) 1.47
MIP-2 secreted by epithelial cells increases neutrophil and lymphocyte recruitment in the mouse intestine. Gut (2001) 1.46
Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients. PLoS One (2010) 1.44
Novel CXCR2-dependent liver regenerative qualities of ELR-containing CXC chemokines. FASEB J (1999) 1.37
Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model. Proc Natl Acad Sci U S A (2010) 1.33
Distinct expression and function of the novel mouse chemokine monocyte chemotactic protein-5 in lung allergic inflammation. J Exp Med (1996) 1.32
Role of cytokines and chemokines in non-alcoholic fatty liver disease. World J Gastroenterol (2012) 1.32
Adipokines in nonalcoholic steatohepatitis: from pathogenesis to implications in diagnosis and therapy. Mediators Inflamm (2009) 1.26
High fat diet induced hepatic steatosis establishes a permissive microenvironment for colorectal metastases and promotes primary dysplasia in a murine model. Am J Pathol (2009) 1.25
Proliferative effects of CXC chemokines in rat hepatocytes in vitro and in vivo. Shock (1998) 1.22
Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis. Am J Physiol Gastrointest Liver Physiol (2011) 1.21
CD1d-restricted natural killer T cells contribute to hepatic inflammation and fibrogenesis in mice. J Hepatol (2010) 1.19
Novel role of IL-13 in fibrosis induced by nonalcoholic steatohepatitis and its amelioration by IL-13R-directed cytotoxin in a rat model. J Immunol (2008) 1.10
Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities. Antioxid Redox Signal (2011) 1.07
Steatosis and hepatocellular carcinoma risk. Eur Rev Med Pharmacol Sci (2005) 1.05
Cytokine stimulation of epithelial cancer cells: the similar and divergent functions of IL-4 and IL-13. Cancer Res (2012) 1.04
Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient diet. Lab Invest (2010) 1.02
Defective hepatic regeneration after partial hepatectomy in leptin-deficient mice is not rescued by exogenous leptin. Lab Invest (2006) 1.02
IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis. PLoS One (2009) 1.01
Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice. Lab Invest (2010) 0.98
Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients. Ann Surg Oncol (2011) 0.97
Steatosis does not impair liver regeneration after partial hepatectomy. Lab Invest (2012) 0.94
Conditionally immortalized mouse hepatocytes for use in liver gene therapy. J Gastroenterol Hepatol (2000) 0.91
Hepatocyte expression of serum response factor is essential for liver function, hepatocyte proliferation and survival, and postnatal body growth in mice. Hepatology (2009) 0.88
Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis. Clin Sci (Lond) (2012) 0.87
TNF expressed by tumor-associated macrophages, but not microglia, can eliminate glioma. Int J Oncol (2007) 0.86
Hepatic steatosis causes induction of the chemokine RANTES in the absence of significant hepatic inflammation. Int J Clin Exp Pathol (2010) 0.85
CXCL16 participates in pathogenesis of immunological liver injury by regulating T lymphocyte infiltration in liver tissue. World J Gastroenterol (2005) 0.80
Involvement of up-regulated CXC chemokine ligand 16/scavenger receptor that binds phosphatidylserine and oxidized lipoprotein in endotoxin-induced lethal liver injury via regulation of T-cell recruitment and adhesion. Infect Immun (2005) 0.78
Effect of leptin and insulin on chick embryonic muscle cells and hepatocytes. Physiol Res (2001) 0.76
Survival and functional quality of life after resection for hepatic carcinoid metastasis. J Gastrointest Surg (2004) 0.83